Global Peripheral Intervention Drug-Eluting Devices Market Size, Share, Trends and Forecast 2021-2027

Description

The global Peripheral Intervention Drug-Eluting Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Peripheral Intervention Drug-Eluting Devices Scope and Segment
Peripheral Intervention Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Peripheral Intervention Drug-Eluting Devices Breakdown Data by Type
Drug-Eluting Balloons
Drug-Eluting Stents
Peripheral Intervention Drug-Eluting Devices Breakdown Data by Application
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Regional and Country-level Analysis
The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peripheral Intervention Drug-Eluting Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.

TABLE OF CONTENT

1 Study Coverage
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Market by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Market by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts 2016-2027
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2016-2027
2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Sales
2.4.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Sales (2016-2021)
2.4.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Sales (2022-2027)
2.5 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue
2.5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2016-2021)
2.5.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers
3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Sales (2016-2021)
3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Sales in 2020
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers
3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2020
3.3 Global Peripheral Intervention Drug-Eluting Devices Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Type (2016-2021)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Type (2022-2027)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2027)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Type (2016-2021)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Type (2022-2027)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2027)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type
4.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021)
4.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Application (2016-2021)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Application (2022-2027)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2027)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Application (2016-2021)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Application (2022-2027)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2027)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application
5.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021)
5.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 North America
6.1 North America Peripheral Intervention Drug-Eluting Devices Market Size by Type
6.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2027)
6.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2027)
6.2 North America Peripheral Intervention Drug-Eluting Devices Market Size by Application
6.2.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2027)
6.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2027)
6.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
6.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2027)
6.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada

7 Europe
7.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Type
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2027)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2027)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Application
7.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2027)
7.2.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2027)
7.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
7.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2027)
7.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Type
8.1.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2027)
8.1.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2027)
8.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Application
8.2.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2027)
8.2.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2027)
8.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
8.3.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2027)
8.3.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines

9 Latin America
9.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Type
9.1.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2027)
9.1.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2027)
9.2 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Application
9.2.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2027)
9.2.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2027)
9.3 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Country
9.3.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2027)
9.3.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Type
10.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2027)
10.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2027)
10.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Application
10.2.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2027)
10.2.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2027)
10.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
10.3.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2027)
10.3.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Medtronic plc
11.1.1 Medtronic plc Corporation Information
11.1.2 Medtronic plc Overview
11.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Description
11.1.5 Medtronic plc Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Corporation Information
11.2.2 Boston Scientific Corporation Overview
11.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Description
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Description
11.3.5 Abbott Laboratories Recent Developments
11.4 Cardinal Health
11.4.1 Cardinal Health Corporation Information
11.4.2 Cardinal Health Overview
11.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Description
11.4.5 Cardinal Health Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Corporation Information
11.5.2 B. Braun Melsungen AG Overview
11.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Description
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 Biosensors International Group Ltd.
11.6.1 Biosensors International Group Ltd. Corporation Information
11.6.2 Biosensors International Group Ltd. Overview
11.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Description
11.6.5 Biosensors International Group Ltd. Recent Developments
11.7 C.R. Bard, Inc.
11.7.1 C.R. Bard, Inc. Corporation Information
11.7.2 C.R. Bard, Inc. Overview
11.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Description
11.7.5 C.R. Bard, Inc. Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Overview
11.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Description
11.8.5 Abbott Recent Developments
11.9 The Lubrizol Corporation
11.9.1 The Lubrizol Corporation Corporation Information
11.9.2 The Lubrizol Corporation Overview
11.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Description
11.9.5 The Lubrizol Corporation Recent Developments
11.10 Terumo Corporation
11.10.1 Terumo Corporation Corporation Information
11.10.2 Terumo Corporation Overview
11.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Description
11.10.5 Terumo Corporation Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Peripheral Intervention Drug-Eluting Devices Value Chain Analysis
12.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
12.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
12.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
12.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
12.5 Peripheral Intervention Drug-Eluting Devices Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
13.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
13.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
13.4 Peripheral Intervention Drug-Eluting Devices Market Restraints

14 Key Findings in The Global Peripheral Intervention Drug-Eluting Devices Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample